Plain-English translation of NCT06950827 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is comparing two surgical approaches to treat hepatocellular carcinoma (a type of liver cancer) by removing the right half of the liver. One approach uses traditional open surgery with a large incision, while the other uses laparoscopic (minimally invasive) surgery with small incisions and a camera. The study wants to understand whether laparoscopic surgery is as safe and effective as traditional open surgery for this procedure.
Laparoscopic surgery offers potential benefits like smaller incisions, less bleeding, and faster recovery compared to traditional open surgery. However, it is technically challenging and not yet widely adopted, so researchers need to confirm whether this newer approach produces equally good outcomes for liver cancer patients.
You likely qualify if…
You likely don't qualify if…
If you qualify for this study, your medical team will assign you to receive either traditional open surgery or minimally invasive laparoscopic surgery to remove the right portion of your liver. After surgery, researchers will follow your recovery and track your health outcomes, including how well you heal, any complications, and your long-term survival. The study involves 400 patients total and will help doctors understand which surgical approach works best for people with your type of cancer.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
China